Streetbeat News

Revenues

META

Meta Platforms is set to report its Q2 earnings on July 31, with analysts focusing on AI advancements and advertising spending. Revenue is estimated at $38.3 billion, up from $32.0 billion last year, and EPS is expected to be $4.73, up from $2.98. Analysts have mixed sentiments, but many maintain an Outperform rating with high price targets. Key items to watch include AI strategy, advertising rates, and potential increases in expenses.

Portfolio Pulse from Chris Katje

July 30, 2024 | 4:24 pm

BA

EADSY

Leonardo's CEO announced plans to return to 'Rate 10' for Boeing fuselages by 2025 and is in talks with Airbus to expand collaboration on the A220's rear fuselage. The company is also negotiating with Boeing over the slowdown in 787 production but sees positive long-term prospects for the B787.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 4:23 pm

AMZN

Amazon projected its healthcare businesses to lose more than $1 billion in 2024, according to an internal document. The company is focusing on cost-cutting measures to achieve profitability in this segment.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 4:22 pm

HSII

Heidrick & Struggles shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 net revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 4:22 pm

NEO

NeoGenomics shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 4:19 pm

AGCO

AGCO Corporation (NYSE:AGCO) shares are trading lower after reporting worse-than-expected Q2 financial results and lowering its FY24 guidance. The company missed analyst expectations for both earnings and sales, and announced significant production cuts and a sale of its Grain & Protein business.

Portfolio Pulse from Nabaparna Bhattacharya

July 30, 2024 | 4:14 pm

CCJ

EGRAF

RIO

Uranium prices have surged to 16-year highs due to supply uncertainties and rising demand, particularly for AI data centers. Cameco (NYSE:CCJ) is locking in higher contract prices, while Energy Resources of Australia (OTCPK:EGRAF) and Rio Tinto (NYSE:RIO) face challenges due to Australia's mining ban at the Jabiluka site.

Portfolio Pulse from Stjepan Kalinic

July 30, 2024 | 4:13 pm

QQQ

SPY

August is historically a weak month for stock market returns, with major indices like the S&P 500, Nasdaq 100, and NYSE Composite showing low to negative average returns. The SPDR S&P 500 ETF (SPY) and Invesco QQQ Trust (QQQ) reflect these trends. Investors should consider seasonality as one of many factors in their trading decisions.

Portfolio Pulse from Cory Mitchell

July 30, 2024 | 4:13 pm

ZBRA

Zebra Technologies Corp (NASDAQ:ZBRA) reported better-than-expected Q2 2024 results, with net sales of $1.22 billion and adjusted EPS of $3.18, both beating analyst estimates. The EVM segment showed strong growth, while the AIT segment saw a decline. The company improved its gross margin but faced higher operating expenses. Zebra expects significant sales growth in Q3 and fiscal 2024, raising its guidance.

Portfolio Pulse from Anusuya Lahiri

July 30, 2024 | 4:10 pm

BMY

MRK

MYNZ

PFE

Pfizer has recorded its first sales growth in the post-COVID era, driven by cancer and heart drugs. Smaller players like Mainz Biomed are also making strides in oncology. Pfizer's Q2 revenue grew 3% YoY to $13.28 billion, with significant contributions from cancer therapies and heart disease drugs. Merck also exceeded estimates, driven by its cancer drug Keytruda. Pfizer raised its full-year outlook, expecting earnings per share between $2.45 and $2.65.

Portfolio Pulse from Upwallstreet

July 30, 2024 | 4:09 pm